200 related articles for article (PubMed ID: 15070245)
1. Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: evaluation of applicator attenuation and superposition approximation effects.
Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E
Med Phys; 2004 Mar; 31(3):493-9. PubMed ID: 15070245
[TBL] [Abstract][Full Text] [Related]
2. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
Selvam TP; Sahoo S; Vishwakarma RS
Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
[TBL] [Abstract][Full Text] [Related]
3. Commissioning a CT-compatible LDR tandem and ovoid applicator using Monte Carlo calculation and 3D dosimetry.
Adamson J; Newton J; Yang Y; Steffey B; Cai J; Adamovics J; Oldham M; Chino J; Craciunescu O
Med Phys; 2012 Jul; 39(7):4515-23. PubMed ID: 22830783
[TBL] [Abstract][Full Text] [Related]
4. Impact of the vaginal applicator and dummy pellets on the dosimetry parameters of Cs-137 brachytherapy source.
Sina S; Faghihi R; Meigooni AS; Mehdizadeh S; Mosleh Shirazi MA; Zehtabian M
J Appl Clin Med Phys; 2011 May; 12(3):3480. PubMed ID: 21844861
[TBL] [Abstract][Full Text] [Related]
5. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
[TBL] [Abstract][Full Text] [Related]
6. Determination of task group 43 dosimetric parameters for CSM40
Firoozabadi MM; Jimabadi E; Ghorbani M; Behmadi M
Radiol Phys Technol; 2018 Mar; 11(1):82-90. PubMed ID: 29299819
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type 137Cs source.
Casal E; Ballester F; Lluch JL; Pérez-Calatayud J; Lliso F
Med Phys; 2000 Jan; 27(1):132-40. PubMed ID: 10659748
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo and experimental derivation of TG43 dosimetric parameters for CSM-type Cs-137 sources.
Pérez-Calatayud J; Granero D; Casal E; Ballester F; Puchades V
Med Phys; 2005 Jan; 32(1):28-36. PubMed ID: 15719951
[TBL] [Abstract][Full Text] [Related]
9. Technical note: Monte Carlo derivation of TG-43 dosimetric parameters for radiation therapy resources and 3M Cs-137 sources.
Pérez-Calatayud J; Granero D; Ballester F; Casal E; Cases R; Agramunt S
Med Phys; 2005 Aug; 32(8):2464-70. PubMed ID: 16193775
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric characteristics of the CDC-type miniature cylindrical 137Cs brachytherapy sources.
Pérez-Calatayud J; Ballester F; Serrano-Andrés MA; Lluch JL; Puchades V; Limami Y; Casal E
Med Phys; 2002 Apr; 29(4):538-43. PubMed ID: 11991125
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator.
Gifford KA; Mourtada F; Cho SH; Lawyer A; Horton JL
Radiother Oncol; 2005 Nov; 77(2):210-5. PubMed ID: 16216363
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
Wang J; Zhang H
Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
[TBL] [Abstract][Full Text] [Related]
14. Sub-second high dose rate brachytherapy Monte Carlo dose calculations with bGPUMCD.
Hissoiny S; D'Amours M; Ozell B; Despres P; Beaulieu L
Med Phys; 2012 Jul; 39(7):4559-67. PubMed ID: 22830787
[TBL] [Abstract][Full Text] [Related]
15. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
Markman J; Williamson JF; Dempsey JF; Low DA
Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the effect of various intracavitary applicators on dosimetric parameters of (192)Ir, (137)Cs, and (60)Co sources.
Ghorbani M; Hashempour M; Azizi M; Meigooni AS
Australas Phys Eng Sci Med; 2016 Jun; 39(2):477-91. PubMed ID: 27168066
[TBL] [Abstract][Full Text] [Related]
17. Validation of GPUMCD for low-energy brachytherapy seed dosimetry.
Hissoiny S; Ozell B; Després P; Carrier JF
Med Phys; 2011 Jul; 38(7):4101-7. PubMed ID: 21859010
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
Poon E; Williamson JF; Vuong T; Verhaegen F
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
[TBL] [Abstract][Full Text] [Related]
20. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
